Wellness (Dietary Supplements)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Regulation / Legislation Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Regulation & Wellness
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
Preemption, Constitution Counter New York Law Age-Restricting Some Supplement Sales – CRN
Trade group’s lawsuit filed 13 March in New York alleges NY General Business Law 391-oo, which the state legislature enacted in October 2023 with 22 April effective date, violates US Constitution’s First and 14th amendments plus corresponding articles of the state’s constitution.
Take Care With ‘Health Lite’ Claims
Some advertisers try to avoid scrutiny of regulators and the National Advertising Division when making health-related claims by making a claim “softer.” Annie Ugurlayan, NAD’s assistant director, offers advice on assuring substantiation and a health claim match.
Latest From Legislation & Wellness
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
Biden Administration's $7.13Bn FDA Budget Request For FY2025 Includes $3.3Bn In User Fees
White House’s 1,298-page budget request published on 11 March includes around $2m more than the agency’s total FY2024 spending Congress approved on 8 March and the president signed the next day. Of FDA’s total FY2025 spending $3.286bn would come from user fees.
FDA Food Programs Chief Assured On Supplement Office Move, Pessimistic On Agency Budget
“We think that this structure actually provides us the best path forward in terms of optimizing on our resources,” Jim Jones says of ODSP move. On the other hand, he says Congress didn’t appropriate for the agency’s optimal operation.
Business Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Deals & Wellness
Herbalife Executives' Investments Spark Uptick In Share Price After Results Send Stock Plummeting
Since closing at a 14-year low of $8.07 the day of the execs’ transactions, Herbalife shares trend steadily up from close of $8.26 on 20 February to $8.83 on 29 February. Some execs sell back some shares on 25 February at $8.67.
C&D Investors, Analysts Not On Same Page
Share price’s recent ride doesn’t track with analysts’ regard for C&D’s results and outlook.
Biocodex Broadens Probiotics Play With Investment in Belgium's My Health
France's Biocodex will introduce to European markets a probiotic supplement targeted as sufferers of functional dyspepsia after taking in a stake the product's manufacturer, My Health.
Latest From Business Strategies & Wellness
Stada Grows Twice As Fast As CHC Market In 2023
Stada's local brand focus helped it deliver Consumer Healthcare sales growth of 16% in 2023 ensuring the German firm significantly outpaced the overall market growth rate of 7%.
Over The Counter 18 Mar 2024: How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen
In this episode, HBW Insight dives into personalized wellness with Marni Allen, chief marketing officer at tailored supplements manufacturer Bioniq. Named as one of EY UK's 50 Women to Watch in 2022, Allen has over 20 years’ experience in consumer healthcare, and is now working with Bioniq to create the next generation of bespoke wellness products for consumers across the world. As well as its top tier at-home blood test-based service, Bioniq also offers an affordable questionnaire-based option, which leverages the power of AI to analyse users’ nutritional needs and provide unique supplement formulations in the post. Although personalized wellness is still somewhat niche, Allen suggests that AI-based models like Bioniq offer an attractive option for traditional consumer health companies looking to get into this fast-growing market.
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
Latest From Sales & Earnings & Wellness
Stada Grows Twice As Fast As CHC Market In 2023
Stada's local brand focus helped it deliver Consumer Healthcare sales growth of 16% in 2023 ensuring the German firm significantly outpaced the overall market growth rate of 7%.
Bayer To Hold On To Consumer Health While It Deals With More Pressing Issues
With Bayer "badly broken in four places," now is not the right time to consider offloading its Consumer Health business, according to group CEO Bill Anderson. Bayer must focus its full attention for the next few years on addressing challenges which include mounting debt and costly litigation before a change to the company's structure can be considered.
Herbalife Executives' Investments Spark Uptick In Share Price After Results Send Stock Plummeting
Since closing at a 14-year low of $8.07 the day of the execs’ transactions, Herbalife shares trend steadily up from close of $8.26 on 20 February to $8.83 on 29 February. Some execs sell back some shares on 25 February at $8.67.
Latest From Legal Issues & Wellness
Ordinary Marketing Or Consumer Trap? Talking ‘Dark Patterns’ With Attorney Lauren Aronson
Whether called “dark patterns,” “shady” online marketing practices, or simply deception on the internet, the issue has taken on high importance at the US Federal Trade Commission and is being tackled by new laws in a growing number of states. Amin Talati Wasserman partner Lauren Aronson discusses in this interview with HBW Insight.
FTC Might Need More Illumination On Proposed Rule For Online Consumer Product Reviews
BBB National Programs found FTC’s proposed Trade Regulation Rule on the Use of Consumer Reviews and Testimonials largely effective with some certainty on whether product reviews or customer testimonials are violations of its false advertising standards. But it =expects some clarifications may come in final rule.
FTC Gives Stage To Critics And Champions Of Online Consumer Product Reviews, Testimonials
Speakers scheduled for hearing are Fake Review Watch, which says it’s “dedicated to exposing the massive corruption of online consumer review platforms”; University of California-Davis researchers who found widespread fraud; and Interactive Advertising Bureau, which says its members account for 86% of online advertising expenditures in the US.
Marketing Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Launches & Wellness
Perrigo Delivering Opill Sales Within A Month, Launches ‘Energize’ Efficiency Project Immediately
Perrigo says 2024 results will be slowed by investment in companywide efficiency project including staff reductions. After Opill’s expected launch by late March, sales will be dilutive to earnings for the first year partly due to investments in the brand, primarily at retailers and online in Q2.
BrainMD Latest To Target GLP-1 Secretion, AllerPops Promotes Prebiotics As Allergy Remedy
Line extension for physician’s brand BrainMD intends to support secretion of glucagon-like peptide-1; research shows AllerPops prebiotic lozenges improved rhinitis allergy symptoms significantly; and Nutramax Laboratories developing Practitioner Formulas supplements with health care professionals.
Bausch + Lomb Rings Bell On 'Largest' Launch Year
Canadian firm’s eye health supplements Occuvite and PreserVision remain top sellers, with ReNu and Biotrue contact lens solutions and Lumify eye drops and skin care line rounding out its top 10 revenue generators.
Latest From Ad Campaigns & Wellness
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
BrainMD Latest To Target GLP-1 Secretion, AllerPops Promotes Prebiotics As Allergy Remedy
Line extension for physician’s brand BrainMD intends to support secretion of glucagon-like peptide-1; research shows AllerPops prebiotic lozenges improved rhinitis allergy symptoms significantly; and Nutramax Laboratories developing Practitioner Formulas supplements with health care professionals.
Kenvue Prioritizes Growing 15 Brands In Pivot To Recovering Marketplace Prominence
Kenvue’s plans to drive sales include re-introducing brands to consumers and making “priority” of 15 brands, most in self care. “Overall, the execution of our recovery plan in the fourth quarter fell short of expectations,” says CEO Thibaut Mongon.
Latest From Ad Complaints & Wellness
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
Take Care With ‘Health Lite’ Claims
Some advertisers try to avoid scrutiny of regulators and the National Advertising Division when making health-related claims by making a claim “softer.” Annie Ugurlayan, NAD’s assistant director, offers advice on assuring substantiation and a health claim match.
ASA Files: How Not To Advertise A CBD Food Supplement In The UK
A recent ASA ruling against UK firm Supreme CBD highlights the need to be transparent about influencer marketing, as well as to avoid making any medicinal claims for food supplements.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.